A Retrospective Epidemiological Study of Natural History of HPV Infections in Women Aged 18 Years and Above With Recurrent Conization Following a Primary Conization for High Grade Lesions/ Microinvasive Cervical Carcinomas, in Norway
This protocol posting has been updated following Protocol Amendment 1 (02 April 2010). The
sections impacted are: enrolment, outcome measures and eligibility criteria.
Observational
Observational Model: Case-Only, Time Perspective: Retrospective
HPV-types as single group considered as new infections in recurrent conizations with high grade lesions, microinvasive cervical carcinomas or ICC diagnosis.
At the end of the study.
No
GSK Clinical Trials
Study Director
GlaxoSmithKline
Norway: Norwegian Medicines Agency
112674
NCT00924794
June 2010
August 2010
Name | Location |
---|